A study of antiretroviral therapy (ART) regimen in people living with HIV in the US before and during the COVID pandemic
Latest Information Update: 01 Feb 2023
At a glance
- Drugs Bictegravir (Primary) ; Dolutegravir (Primary) ; Dolutegravir/lamivudine (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 05 Feb 2022 New trial record